Optimal Management of High-risk Stage I Nonseminoma Germ Cell Tumor: Active Intervention is the Preferred Option

Scott M Gilbert1, Wade J Sexton1

  • 1H. Lee Moffitt Cancer Center & Research Institute, Department of Genitourinary Oncology, Tampa, FL, USA.

European Urology Focus
|October 1, 2019
PubMed